Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Piotr Popik

Showing results (81-90 of 133) with videos related to

Pageof 14
Sort By:
Neuropharmacology|November 5, 2016
3-Furan-2-yl-N-p-tolyl-acrylamide, a positive allosteric modulator of the α7 nicotinic receptor, reverses schizophrenia-like cognitive and social deficits in ratsAgnieszka Potasiewicz, Małgorzata Hołuj, Tomasz Kos, et al.
Journal of Psychopharmacology (Oxford, England)|December 26, 2025
Effects of ketamine enantiomers on morphine and THC subjective effects in ratsNatalia Malikowska-Racia, Joanna Golebiowska, Katarzyna Starowicz, et al.
Pharmacological Reports : PR|July 21, 2012
Morphine-induced place preference affects mRNA expression of G protein α subunits in rat brainAgnieszka Zelek-Molik, Adam Bielawski, Grzegorz Kreiner, et al.
Plos One|November 8, 2024
Deep learning algorithms reveal increased social activity in rats at the onset of the dark phase of the light/dark cyclePiotr Popik, Ewelina Cyrano, Joanna Golebiowska, et al.
Journal of Medicinal Chemistry|April 27, 2026
Dually Acting Ligands Targeting Serotonin Receptors: Implications in CNS DisordersWojciech Trybała, Katarzyna Grychowska, Natalia Malikowska-Racia, et al.
Neuropharmacology|March 14, 2020
Social dysfunction in the neurodevelopmental model of schizophrenia in male and female rats: Behavioural and biochemical studiesAgnieszka Potasiewicz, Malgorzata Holuj, Ewa Litwa, et al.
Neuropharmacology|November 19, 2018
Evaluation of ultrasonic vocalizations in a neurodevelopmental model of schizophrenia during the early life stages of ratsAgnieszka Potasiewicz, Malgorzata Holuj, Diana Piotrowska, et al.
CNS Drug Reviews|September 9, 2006
Preclinical and clinical pharmacology of DOV 216,303, a "triple" reuptake inhibitorPhil Skolnick, Philip Krieter, Joseph Tizzano, et al.
Pharmacological Reports : PR|October 23, 2013
Involvement of NMDA and AMPA receptors in the antidepressant-like activity of antidepressant drugs in the forced swim testMałgorzata Wolak, Agata Siwek, Bernadeta Szewczyk, et al.
Journal of Psychopharmacology (Oxford, England)|August 28, 2019
Serotonin type 5A receptor antagonists inhibit D-lysergic acid diethylamide discriminatory cue in ratsPiotr Popik, Martyna Krawczyk, Agata Kuziak, et al.
Pageof 14

Showing results (81-90 of 133) with videos related to

Sort By:
Pageof 14
Neuropharmacology|November 5, 2016
3-Furan-2-yl-N-p-tolyl-acrylamide, a positive allosteric modulator of the α7 nicotinic receptor, reverses schizophrenia-like cognitive and social deficits in ratsAgnieszka Potasiewicz, Małgorzata Hołuj, Tomasz Kos, et al.
Journal of Psychopharmacology (Oxford, England)|December 26, 2025
Effects of ketamine enantiomers on morphine and THC subjective effects in ratsNatalia Malikowska-Racia, Joanna Golebiowska, Katarzyna Starowicz, et al.
Pharmacological Reports : PR|July 21, 2012
Morphine-induced place preference affects mRNA expression of G protein α subunits in rat brainAgnieszka Zelek-Molik, Adam Bielawski, Grzegorz Kreiner, et al.
Plos One|November 8, 2024
Deep learning algorithms reveal increased social activity in rats at the onset of the dark phase of the light/dark cyclePiotr Popik, Ewelina Cyrano, Joanna Golebiowska, et al.
Journal of Medicinal Chemistry|April 27, 2026
Dually Acting Ligands Targeting Serotonin Receptors: Implications in CNS DisordersWojciech Trybała, Katarzyna Grychowska, Natalia Malikowska-Racia, et al.
Neuropharmacology|March 14, 2020
Social dysfunction in the neurodevelopmental model of schizophrenia in male and female rats: Behavioural and biochemical studiesAgnieszka Potasiewicz, Malgorzata Holuj, Ewa Litwa, et al.
Neuropharmacology|November 19, 2018
Evaluation of ultrasonic vocalizations in a neurodevelopmental model of schizophrenia during the early life stages of ratsAgnieszka Potasiewicz, Malgorzata Holuj, Diana Piotrowska, et al.
CNS Drug Reviews|September 9, 2006
Preclinical and clinical pharmacology of DOV 216,303, a "triple" reuptake inhibitorPhil Skolnick, Philip Krieter, Joseph Tizzano, et al.
Pharmacological Reports : PR|October 23, 2013
Involvement of NMDA and AMPA receptors in the antidepressant-like activity of antidepressant drugs in the forced swim testMałgorzata Wolak, Agata Siwek, Bernadeta Szewczyk, et al.
Journal of Psychopharmacology (Oxford, England)|August 28, 2019
Serotonin type 5A receptor antagonists inhibit D-lysergic acid diethylamide discriminatory cue in ratsPiotr Popik, Martyna Krawczyk, Agata Kuziak, et al.
Pageof 14